Genus plc
GENSFOTCHealthcare● Active
$35.00
+$3.94(+12.67%)
Market Cap$2.3B
P/E Ratio—
52W High$37.25
52W Low$26.01
Genus plc (GENSF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GENSF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 26, 2026EPS Actual
$0.81
Revenue
$0.45B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 26, 2026
After Market Close
GENSF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.59B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.59B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 10, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Feb 26, 2026 | — | $0.81 | — | $0.45B | — | — |
| — Q3 FY2025 | Sep 4, 2025 | — | $0.36 | — | $0.46B | — | — |
| — Q1 FY2025 | Feb 27, 2025 | — | $0.03 | — | $0.42B | — | — |
| ◌ Q3 FY2024 | Sep 5, 2024 | — | — | — | — | — | — |
| — Q2 FY2024 | Jun 30, 2024 | — | -$0.05 | — | $0.21B | — | — |
| ◌ Q2 FY2024 | Apr 30, 2024 | — | — | — | — | — | — |
| ▼ Q1 FY2024 | Feb 22, 2024 | $0.42 | $0.13 | -69.3% | $0.21B | $0.43B | -50.7% |
Q3 FY2026
Sep 10, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 26, 2026
EPS Actual
$0.81
EPS Est.
—
EPS Surpr.
—
Revenue
$0.45B
Q3 FY2025
Sep 4, 2025
EPS Actual
$0.36
EPS Est.
—
EPS Surpr.
—
Revenue
$0.46B
Q1 FY2025
Feb 27, 2025
EPS Actual
$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.42B
Q3 FY2024
Sep 5, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 30, 2024
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.21B
Q2 FY2024
Apr 30, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 22, 2024Miss
EPS Actual
$0.13
EPS Est.
$0.42
EPS Surpr.
-69.3%
Revenue
$0.21B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 26, 2026 | — | $37.25 | $37.25 | +0.00% |
| — Q3 FY2025 | Sep 4, 2025 | — | $35.15 | $35.15 | +0.00% |
| — Q1 FY2025 | Feb 27, 2025 | — | $22.50 | $22.50 | +0.00% |
| — Q2 FY2024 | Jun 30, 2024 | — | $21.13 | $21.13 | +0.00% |
| ▼ Q1 FY2024 | Feb 22, 2024 | -69.3% | $28.01 | $28.01 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $35.13 | $35.13 | +0.00% |
| — Q4 FY2022 | Dec 30, 2022 | — | $34.40 | $34.40 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 26, 2026
EPS Beat/Miss
—
Price Before
$37.25
Price After
$37.25
Q3 FY2025+0.00%
Report Date
Sep 4, 2025
EPS Beat/Miss
—
Price Before
$35.15
Price After
$35.15
Q1 FY2025+0.00%
Report Date
Feb 27, 2025
EPS Beat/Miss
—
Price Before
$22.50
Price After
$22.50
Q2 FY2024+0.00%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$21.13
Price After
$21.13
Q1 FY2024+0.00%
Report Date
Feb 22, 2024
EPS Beat/Miss
-69.3%
Price Before
$28.01
Price After
$28.01
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$35.13
Price After
$35.13
Q4 FY2022+0.00%
Report Date
Dec 30, 2022
EPS Beat/Miss
—
Price Before
$34.40
Price After
$34.40
Avg Miss Reaction+0.00%
Beat Rate0 / 7 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GENSF ends December
Genus plc (GENSF) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $0.81 (in line with the analyst consensus of —). The next GENSF earnings date is expected around September 1, 2026.
Each quarter, investors track GENSF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GENSF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GENSF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GENSF earnings · 4 questionsGenus plc's next earnings report is expected around September 1, 2026. GENSF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GENSF historically reports after market close (AMC).
GENSF earnings datewhen is GENSF earningsGENSF next earnings datewhen does GENSF report earningsGENSF earnings calendar
▸ Source: FMP · Genus plc SEC filings · US GAAP · Genus plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026